{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:01:21Z","timestamp":1769018481187,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,14]]},"DOI":"10.7759\/cureus.60298","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T18:10:13Z","timestamp":1715710213000},"source":"Crossref","is-referenced-by-count":4,"title":["A Rare Case of Bicalutamide-Induced Severe Congestive Heart Failure in a Patient With Advanced Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Ammar Y","family":"Abdulfattah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Tajuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Akkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar I","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzette","family":"Graham-Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00518-5","article-title":"Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study","volume":"17","author":"Shore ND","year":"2016","unstructured":"Shore ND, Chowdhury S, Villers A, et al.. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. Lancet Oncol. 2016, 17:153-63. 10.1016\/S1470-2045(15)00518-5","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana JC","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, et al.. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014, 27:911-39. 10.1016\/j.echo.2014.07.012","journal-title":"J Am Soc Echocardiogr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1988.tb04364.x","article-title":"Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation","volume":"62","author":"Kreis W","year":"1988","unstructured":"Kreis W, Ahmann FR, Jordan VC, de Haan H, Scott M. Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation. Br J Urol. 1988, 62:352-4. 10.1111\/j.1464-410x.1988.tb04364.x","journal-title":"Br J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.05.012","article-title":"Combined blockade of testicular and locally made androgens in prostate cancer: a highly significant medical progress based upon intracrinology","volume":"145","author":"Labrie F","year":"2015","unstructured":"Labrie F. Combined blockade of testicular and locally made androgens in prostate cancer: a highly significant medical progress based upon intracrinology. J Steroid Biochem Mol Biol. 2015, 145:144-56. 10.1016\/j.jsbmb.2014.05.012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.02184.x","article-title":"Combined androgen blockade in prostate cancer: meta-analyses and associated issues","volume":"87","author":"Klotz L","year":"2001","unstructured":"Klotz L. Combined androgen blockade in prostate cancer: meta-analyses and associated issues. BJU Int. 2001, 87:806-13. 10.1046\/j.1464-410x.2001.02184.x","journal-title":"BJU Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0738-5","article-title":"Patterns of bicalutamide use in prostate cancer treatment: a U.S. real-world analysis using the SEER-Medicare Database","volume":"35","author":"Beebe-Dimmer JL","year":"2018","unstructured":"Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, et al.. Patterns of bicalutamide use in prostate cancer treatment: a U.S. real-world analysis using the SEER-Medicare Database. Adv Ther. 2018, 35:1438-51. 10.1007\/s12325-018-0738-5","journal-title":"Adv Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(96)80003-3","article-title":"The preclinical development of bicalutamide: pharmacodynamics and mechanism of action","volume":"25","author":"Furr BJ","year":"1996","unstructured":"Furr BJ, Tucker H. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology. 1996, 25:9-32. 10.1016\/s0090-4295(96)80003-3","journal-title":"Urology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2008.23","article-title":"Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines","volume":"12","author":"Floyd MS Jr","year":"2009","unstructured":"Floyd MS Jr, Teahan SJ, Fitzpatrick JM, Watson RW. Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines. Prostate Cancer Prostatic Dis. 2009, 12:25-33. 10.1038\/pcan.2008.23","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02999.x","article-title":"Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer","volume":"68","author":"Dockery F","year":"2008","unstructured":"Dockery F, Bulpitt CJ, Agarwal S, et al.. Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer. Clin Endocrinol (Oxf). 2008, 68:59-65. 10.1111\/j.1365-2265.2007.02999.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1332","article-title":"Androgen deprivation therapy use increases the risk of heart failure in patients with prostate cancer: a population-based cohort study","volume":"59","author":"Kao HH","year":"2019","unstructured":"Kao HH, Kao LT, Li IH, Pan KT, Shih JH, Chou YC, Wu ST. Androgen deprivation therapy use increases the risk of heart failure in patients with prostate cancer: a population-based cohort study. J Clin Pharmacol. 2019, 59:335-43. 10.1002\/jcph.1332","journal-title":"J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.10.032","article-title":"Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist","volume":"65","author":"Albertsen PC","year":"2014","unstructured":"Albertsen PC, Klotz L, Tombal B, Grady J, Olesen TK, Nilsson J. Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist. Eur Urol. 2014, 65:565-73. 10.1016\/j.eururo.2013.10.032","journal-title":"Eur Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411694200","article-title":"Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis","volume":"280","author":"Ikeda Y","year":"2005","unstructured":"Ikeda Y, Aihara K, Sato T, et al.. Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J Biol Chem. 2005, 280:29661-6. 10.1074\/jbc.M411694200","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1254","article-title":"Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling","volume":"150","author":"Ikeda Y","year":"2009","unstructured":"Ikeda Y, Aihara K, Yoshida S, et al.. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling. Endocrinology. 2009, 150:2857-64. 10.1210\/en.2008-1254","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s1071-9164(99)90035-0","article-title":"Peripheral vascular remodeling in chronic heart failure: clinical relevance and new conceptualization of its mechanisms","volume":"5","author":"Nakamura M","year":"1999","unstructured":"Nakamura M. Peripheral vascular remodeling in chronic heart failure: clinical relevance and new conceptualization of its mechanisms. J Card Fail. 1999, 5:127-38. 10.1016\/s1071-9164(99)90035-0","journal-title":"J Card Fail"},{"key":"ref16","article-title":"Emerging pharmacologic therapies for prostate cancer","volume":"3","author":"Trachtenberg J","year":"2001","unstructured":"Trachtenberg J. Emerging pharmacologic therapies for prostate cancer. Rev Urol. 2001, 3:S23-8.","journal-title":"Rev Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1131819","article-title":"Bicalutamide causes heart failure in an elderly patient with prostate cancer","volume":"15","author":"Guirguis K","year":"2016","unstructured":"Guirguis K. Bicalutamide causes heart failure in an elderly patient with prostate cancer. Expert Opin Drug Saf. 2016, 15:297-302. 10.1517\/14740338.2015.1131819","journal-title":"Expert Opin Drug Saf"},{"key":"ref18","article-title":"Defining the basis of an operational model for enhanced efficacy of combination therapy using an endothelin receptor antagonist and chemotherapeutic agents","volume":"6","author":"Pflug B","year":"2007","unstructured":"Pflug B, McHugh K, D'Antonio J, Bocola-Mavar E, Curwen J, Growcott J, Nelson J. Defining the basis of an operational model for enhanced efficacy of combination therapy using an endothelin receptor antagonist and chemotherapeutic agents. Mol Cancer Ther. 2007, 6:287.","journal-title":"Mol Cancer Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.000455","article-title":"Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure","volume":"114","author":"Woo YJ","year":"2006","unstructured":"Woo YJ, Panlilio CM, Cheng RK, et al.. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation. 2006, 114:I206-13. 10.1161\/CIRCULATIONAHA.105.000455","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000529","article-title":"The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines","volume":"36","author":"Katayama H","year":"2010","unstructured":"Katayama H, Murashima T, Saeki Y, Nishizawa Y. The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines. Int J Oncol. 2010, 36:553-62. 10.3892\/ijo_00000529","journal-title":"Int J Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253533-a-rare-case-of-bicalutamide-induced-severe-congestive-heart-failure-in-a-patient-with-advanced-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T18:10:19Z","timestamp":1715710219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253533-a-rare-case-of-bicalutamide-induced-severe-congestive-heart-failure-in-a-patient-with-advanced-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.60298","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,14]]}}}